Caris MI Profile® – How IHC Can Make or Break a Patient’s Molecular Profile

Event Details

Date: June 24, 2026

Time: 19:00 BST

Immunohistochemistry (IHC) remains central to precision oncology – but how much does it really influence the final molecular profile?

In this educational webinar, we explore how IHC can make or break a patient’s Caris MI Profile® – and what happens when IHC results interact with whole exome sequencing (WES) and whole transcriptome sequencing (WTS) findings in complex cancers.

Through practical case examples, you’ll see how IHC drives real clinical decisions – reducing diagnostic uncertainty and helping guide therapy selection where it matters most.

Speakers

Dr Sachein Sharma, MD, MPH
Caris Life Sciences

Session Chair

Prof Hendrik-Tobias Arkenau, MD, PhD
EDX Medical

Programme

What you’ll learn

Where IHC fits within integrated molecular profiling
How WES, WTS, and IHC work together in Caris MI Profile
Practical application of IHC in challenging clinical scenarios
How molecular and protein-level data support therapy selection

About Caris MI Profile

Caris MI Profile® delivers comprehensive tumour profiling across DNA, RNA, and proteins, integrating whole exome sequencing (WES), whole transcriptome sequencing (WTS), and immunohistochemistry (IHC) to reveal a more complete molecular blueprint of cancer.

By assessing more than 23,000 genes alongside clinically relevant IHC markers, Caris MI Profile helps reduce diagnostic uncertainty, identify actionable biomarkers, and support more precise, individualized treatment decisions across solid tumours

Webinar Form

First Name

Last Name

Job title

Organisation name

Address

City

Country

Do you have any specific questions you'd like addressed during the webinar?

I agree to the processing of personal data